Expensify, Inc.
NASDAQ:EXFYSoftware - Application
+$0.35 today
- Market cap
- $157.19M
- Beta
- 1.80
- P/E (TTM)
- -7.0
- EPS (TTM)
- -$0.22
Volume 0.63M
Average 0.79M
EXFY EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Expensify, Inc.NASDAQ: EXFY
EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026
EPS (Diluted) remains negative
Q1 FY2026 EPS (Diluted) was -$0.02, compared with -$0.03 a year earlier. Trailing-twelve-month EPS (Diluted) was -$0.22.
Context
- EPS (Diluted) grew in size in 2 of the last 3 fiscal years.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 2 analysts of $0.13 (+156.5%) for the fiscal year ending Dec 2026, a step up from the -91.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$0.02+67.5% QoQ
- Last fiscal yearDec 2025
- -$0.23-91.7% YoY
- LTMMar 2026
- -$0.22-109.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +28.0% | +121.0% | +93.0 pp |
| 1 year | -91.7% | +156.5% | +248.2 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- (0.23) USD
- Year-over-year change
- -91.7%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (0.23) | -91.7% |
| FY2024 | 2024-12-31 | (0.12) | +76.0% |
| FY2023 | 2023-12-31 | (0.50) | -51.5% |
| FY2022 | 2022-12-31 | (0.33) | -94.1% |
| FY2021 | 2021-12-31 | (0.17) | — |
EPS (Diluted) vs competitors
How EXFY compares with its peers on the latest reported figures
- EXFY's LTM Mar 2026 EPS (Diluted) of -$0.22 is the 4th highest of the 10 companies compared; the peer median is -$0.27.
- Its year-over-year change of -109.2% is the 7th highest of 10, against a peer median of -76.9%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $0.14 | +370.3% | — | |
| LTM Mar 2026 | $0.08 | -21.0% | — | |
HITHealth In Tech, Inc. | LTM Mar 2026 | -$0.02 | -197.0% | +137.1% |
| LTM Mar 2026 | -$0.22 | -109.2% | — | |
| FY2025 | -$0.23 | -76.9% | — | |
| LTM Mar 2026 | -$0.27 | +31.4% | — | |
SVCOSilvaco Group, Inc. Common Stock | LTM Mar 2026 | -$0.93 | +59.7% | — |
| LTM Mar 2026 | -$1.17 | -92.2% | — | |
| LTM Mar 2026 | -$1.52 | -811.3% | — | |
TEADTeads Holding Co. | LTM Mar 2026 | -$5.24 | -362.3% | — |
| Peer median (excluding EXFY) | -$0.27 | -76.9% | +137.1% | |
Competitors are the stored peer set for EXFY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 142.84M | 169.5M | 150.69M | 139.24M | 142.1M |
| Cost of Revenue | 53.69M | 62.67M | 66.89M | 64.24M | 70.57M |
| Gross Profit | 89.14M | 106.83M | 83.8M | 75M | 71.53M |
| Gross Margin | 62.4% | 63.0% | 55.6% | 53.9% | 50.3% |
| Research & Development | 10.99M | 13.69M | 23.37M | 24.64M | 20.68M |
| Selling, General & Admin | 88.41M | 108.37M | 93.58M | 51.18M | 68.86M |
| Operating Expenses | 99.39M | 122.06M | 116.95M | 75.82M | 89.55M |
| Depreciation & Amortization | 5.2M | 6.05M | 5.16M | 6.81M | 8.46M |
| EBITDA | (5.06M) | (9.18M) | (27.99M) | 5.99M | (7.83M) |
| EBITDA Margin | -3.5% | -5.4% | -18.6% | 4.3% | -5.5% |
| Operating Income | (10.25M) | (15.23M) | (33.15M) | (820K) | (18.02M) |
| Operating Margin | -7.2% | -9.0% | -22.0% | -0.6% | -12.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.48M | 5.41M | 5.33M | 1.57M | 0 |
| Other Income / Expenses | (3.48M) | (5.41M) | (5.33M) | (1.57M) | 1.73M |
| Income Before Tax | (13.73M) | (20.64M) | (38.48M) | (2.39M) | (16.29M) |
| Pre-Tax Margin | -9.6% | -12.2% | -25.5% | -1.7% | -11.5% |
| Income Tax Expense | (174K) | 6.37M | 2.98M | 7.66M | 5.1M |
| Net Income | (13.56M) | (27.01M) | (41.46M) | (10.06M) | (21.39M) |
| Net Margin | -9.5% | -15.9% | -27.5% | -7.2% | -15.1% |
| EPS (Basic) | (0.17) | (0.33) | (0.50) | (0.12) | (0.23) |
| EPS (Diluted) | (0.17) | (0.33) | (0.50) | (0.12) | (0.23) |
| Weighted Avg Shares | 81.4M | 80.79M | 82.49M | 87.38M | 92.28M |
| Weighted Avg Shares (Diluted) | 81.4M | 80.79M | 82.49M | 87.38M | 92.28M |
Expensify, Inc.
NASDAQ:EXFY
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.